Simon Melov

Yo, so let me tell you about Simon Melov, this guy’s the real deal in biotech, and his story is pretty damn inspiring. Basically, he’s one of those scientists who looked at aging and said, “Nah, this bullshit doesn’t have to be the end,” and jumped into startup land to actually do something about it.

Simon did his PhD in Biochemistry at the University of London, and before he even thought about startups, he was crushing it in academia, teaching at Emory, working at the University of Colorado, and then landing a gig as an associate professor at the Buck Institute, which is basically the mecca for aging research. The dude’s been deep in the molecular weeds, studying mitochondria, oxidative stress, and how these things drive aging and age-related diseases like osteoporosis and heart issues. He’s not just talking theory, though, his research showed that stuff like strength training can actually flip some of those aging genes back to a more youthful state. That’s pretty wild.

But here’s where it gets even more interesting. Simon wasn’t content just doing research and publishing papers. He wanted to turn what he knew into something real, something that could actually help people live longer, healthier lives. So, he co-founded Gerostate Alpha with some fellow aging nerds from the Buck Institute, Gordon Lithgow and Mark Lucanic. They saw the possible to develop new therapeutics aimed at tackling aging itself, not just the symptoms. Think about that, trying to slow down or even reverse aging at the biological level? That’s some advanced shit.

And get this, they jumped into Y Combinator in 2018, which is basically the startup Olympics for tech and biotech. That move shows he’s got the hustle and belief that this isn’t just a pipe dream. They based the company in Novato, California, and they’ve been pushing hard ever since. No cap, they’re working on some seriously modern stuff to find the major modulators of aging, stuff that could change the game for everyone.

What does this say about Simon? To me, he’s the embodiment of someone who’s deeply curious, driven by a real desire to fix bullshit health issues, and not afraid to jump into the unknown. He’s been in academia, yeah, but he saw that to actually make an impact, he had to get his hands dirty and start a company. That takes guts, especially in a field as complex and risky as biotech.

His process, from studying aging at the molecular level to building a startup funded by the best in the game, shows he’s all about pushing boundaries. He’s not just in it for the science, he’s in it to change lives. And honestly, that’s what makes him a boss. He’s out here trying to crack one of the biggest mysteries: how to extend healthy lifespan, and he’s doing it with that mix of hardcore science and startup grit. No bullshit, Simon Melov is someone to watch if you care about the future of health and longevity.